FineHeart Widens International IP Protection for FlowMaker®
FineHeart S.A., a clinical stage medical device company developing innovative devices for cardiology today announced the successful filing of six new international patents for its FlowMaker®, a fully implantable device for the treatment of patients with advanced heart failure.
- FineHeart S.A., a clinical stage medical device company developing innovative devices for cardiology today announced the successful filing of six new international patents for its FlowMaker®, a fully implantable device for the treatment of patients with advanced heart failure.
- 3 new U.S. patents, a 3rd headline patent in China, 2 patents in India and in Japan strengthen FineHeart's international reputation, particularly in the Asian markets which are highly protective and difficult to access in terms of intellectual and industrial protection.
- We are also very proud of our patent in Japan, where the excellence of our technology is recognised in a fast moving medical device market.
- The technological innovations of the FlowMaker® underline our ongoing commitment to improving cardiac care for all patients worldwide."